Leila Rooshenas

Leila is a Professor of social medicine and health policy. Her research focuses on social and behavioural factors that shape generation and implementation of evidence- especially in relation to clinical trials and feasibility studies. Leila has a particular interest in addressing over-treatment and de-implementation of ineffective/harmful treatments to improve patient outcomes and enhance the efficiency and sustainability of healthcare. Leila currently leads the QuinteT research group, which specialises in development and application of methods and training to supprt the design and conduct of challenging RCTs (e.g. those deemed difficult to recruit to): http://www.bristol.ac.uk/population-health-sciences/research/groups/social-sciences-health/quintet/ Leila is also a member of the Centre for Surgical Research, the NIHR Bristol Biomedical Research Centre (Academic Capacity Development co-lead, and workstream co-lead for Surgical and Orthopaedic Innovation), and Health Economics and Health Policy. Leila is keen to support PhD/MSc candidates, particularly those with an interest in qualitative/mixed-methods, trials methodology and de-implementation. She teaches and leads units on several MScs and undergraduate programmes within Bristol Medical School.

[30/03/2026] De-implementation of healthcare interventions post-COVID-19: evidence from the Evidence-Based Interventions (EBI) programme in England [01/12/2026] Exploring spillover effects following surgical de-implementation [01/05/2026] Influences on recruitment and retention to mental health randomized controlled trials from the perspective of trial staff: a qualitative evidence synthesis [01/02/2026] Preferences for healthcare decisional control in older people with chronic kidney disease in the UK indicate strong inclinations towards active and collaborative approaches [26/02/2026] A multi-site evaluation of the governance of surgical innovation